Yoshiyuki Kondo Selected Research

Type 2M Limb-Girdle Muscular Dystrophy

9/2010

[Limb-girdle muscular dystrophy type 2M with adult-onset loss of ambulation. A case report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiyuki Kondo Research Topics

Disease

7	Neoplasms (Cancer) 07/2020 - 05/2002
2	Lymphoma (Lymphomas) 01/2018 - 08/2006
2	Muscular Dystrophies (Muscular Dystrophy) 06/2016 - 09/2010
1	Lymphadenopathy 11/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2020
1	Multiple Myeloma 01/2020
1	Lymphedema (Milroy Disease) 01/2019
1	Leukocytosis (Pleocytosis) 01/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Vision Disorders (Hemeralopia) 01/2018
1	Ocular Paraneoplastic Syndromes 01/2018
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Hyperphosphatemia 08/2017
1	Facioscapulohumeral Muscular Dystrophy 06/2016
1	Muscular Diseases (Myopathy) 06/2016
1	Epilepsy (Aura) 07/2015
1	Encephalitis (Encephalitis, Rasmussen) 07/2015
1	Inflammation (Inflammations) 07/2015
1	Disease Progression 07/2015
1	Granuloma 12/2012
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 12/2012
1	Type 2M Limb-Girdle Muscular Dystrophy 09/2010
1	Cardiomyopathies (Cardiomyopathy) 09/2010
1	Dyshidrotic Eczema (Pompholyx) 08/2010
1	Muscle Weakness 08/2010
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2008
1	Carcinoma (Carcinomatosis) 08/2006
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2006
1	Carcinogenesis 02/2005
1	Adenocarcinoma 02/2005
1	Extramammary Paget Disease (Paget Disease, Extramammary) 05/2002
1	Mammary Paget's Disease 05/2002

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 06/2016 - 07/2015
2	EnzymesIBA 09/2010 - 02/2005
2	GlycogenIBA 08/2007 - 02/2004
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 07/2020
1	carfilzomibIBA 01/2020
1	daratumumabIBA 01/2020
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	ibrutinibIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	ParaproteinsIBA 01/2018
1	lanthanum carbonate (Fosrenol)FDA Link 08/2017
1	Anti-Idiotypic AntibodiesIBA 06/2016
1	Signal Recognition ParticleIBA 06/2016
1	AutoantibodiesIBA 07/2015
1	N-Methylaspartate (NMDA)IBA 07/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 07/2015
1	Crystalloid SolutionsIBA 12/2012
1	Amylases FDA Link 12/2012
1	Dystroglycans (Dystroglycan)IBA 09/2010
1	Angiotensin IIIBA 09/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2010
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2010
1	Anti-Allergic Agents (Antiallergic Agents)IBA 08/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2008
1	AntralIBA 08/2006
1	RNA (Ribonucleic Acid)IBA 08/2006
1	beta CateninIBA 02/2005
1	Biotin (Vitamin H)FDA Link 02/2005
1	CollagenIBA 02/2004
1	Capsules (Microcapsules)IBA 02/2004
1	MucinsIBA 05/2002
1	Gastric MucinsIBA 05/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2019 - 01/2019
2	Therapeutics 01/2019 - 08/2010
1	Stem Cell Transplantation 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Telescopes 01/2018